MCMeihua Chen

Meihua Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meihua Chen has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Haohao Liu

    Department of Periodontics, Shanghai Stomatological Hospital and School of Stomatology, Fudan University, Shanghai, China; Shanghai Key Laboratory of Craniomaxillofacial Development and Diseases, Fudan University, Shanghai, China

    2 shared publications
  • Jichun Li

    2 shared publications
  • Junlin He

    Department of Periodontics, Shanghai Stomatological Hospital and School of Stomatology, Fudan University, Shanghai, China; Shanghai Key Laboratory of Craniomaxillofacial Development and Diseases, Fudan University, Shanghai, China

    2 shared publications
  • Mudi Guo

    Department of Periodontics, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, China; Shanghai Key Laboratory of Craniomaxillofacial Development and Diseases, Fudan University, China

    2 shared publications
  • Xiaoling Wei

    Department of Endodontics, Shanghai Stomatological Hospital and School of Stomatology Fudan University Shanghai China

    2 shared publications
  • Yonghui Deng

    Fudan University

    2 shared publications

Latest Publications

  • Open Access

    Macroporous polymer microspheres supported functional nanocrystals for efficient catalysis and antibacterial applications

    by Zhuyu Liu, Yan Wang, Jichun Li, Yue Sun, Meihua Chen, Xiu-Feng Hou, Yonghui Deng

    Porous polymer-nanocrystals (NCs) organic-inorganic nanocomposites with integrated functions, enhanced stability, and controlled morphology are highly demanded across various fields due to their unique physicochemical properties. Herein, uniform macroporous polystyrene (MPS) microspheres loaded with various functional NCs were designed and synthesized through a facile and controllable impregnation method, enabling the applications of nanocrystals in solutions and their convenient recycling and recovery. As a typical example, Ag-loaded MPS composite (denoted as Ag@MPS) microspheres are synthesized and they exhibit uniform spherical morphology, good dispersion, and an interconnected macroporous structure. Benefiting from these distinctive structural features, Ag@MPS microspheres demonstrate exceptional catalytic performance in the reduction of 4-nitrophenol, achieving a fast reaction rate constant of 0.394 min-1 at room temperature. Moreover, owing to the highly accessible Ag NCs in the macroporous PS matrix, the Ag@MPS microspheres display superior antibacterial activity, with antibacterial rates of 93% against Gram-positive bacteria and 99% against Gram-negative bacteria.


  • Insights into the variations in microbial community structure during the development of periodontitis and its pathogenesis

    by Junlin He, Yefei Liu, Hongzhen Xu, Xiaolin Wei, Meihua Chen

    Objective To characterize the subgingival microbiota in subjects with stage I/II periodontitis (moderate periodontitis, MP), stage III/IV periodontitis (severe periodontitis, SP), and periodontal health (PH) at the same probing depth (PD) (shallow ≤ 3 mm, moderate 4–6 mm, or deep ≥ 7 mm), and to investigate the changes associated with probing depth progression. Materials and methods 100 subgingival plaque samples were collected from 50 subjects (16 MP, 17 SP and 17 PH), forming six groups: PHS (PH, shallow), MPS (MP, shallow), MPM (MP, moderate), SPS (SP, shallow), SPM (SP, moderate), and SPD (SP, deep). Samples were analyzed using high-throughput sequencing. Result The subgingival microbiome showed significant differences associated with both PD and periodontitis stage (p < 0.05). With increasing PD, alpha diversity initially increased and then decreased. Pathogenic genera like Fusobacterium, Filifactor, and Porphyromonas increased, while health-associated genera like Streptococcus and Haemophilus decreased. At shallow sites, the PHS, MPS, and SPS groups showed similar community structure. At moderate and deep sites, the SPM and SPD groups exhibited significant differences in community structure compared to the MPM group, with the SPM and SPD groups showing decreased abundances of Actinomyces and increased abundances of Treponema. The microbial co-networks in the SPD and SPM groups exhibited greater complexity and connectivity and were more resilient to random microbial or node removal. Conclusions The subgingival microbiome shows strong associations with PD and periodontitis stage. Clinical relevance Once periodontitis progresses to stage III/IV, reconstructing a healthy subgingival microbiome may be challenging, emphasizing the importance of early prevention.


  • Open Access

    A Regiospecific Co-Assembly Method to Functionalize Ordered Mesoporous Metal Oxides with Customizable Noble Metal Nanocrystals

    by Jichun Li, Lingxiao Xue, Yu Deng, Xiaowei Cheng, Junhao Ma, Wenhe Xie, Meihua Chen, Yonghui Deng

    An efficient regiospecific co-assembly (RSCA) strategy is developed for general synthesis of mesoporous metal oxides with pore walls precisely decorated by highly dispersed noble metal nanocrystals with customized parameters (diameter and composition). It features the rational utilization of the specific interactions between hydrophilic molecular precursors, hydrophobic noble metal nanocrystals, and amphiphilic block copolymers, to achieve regiospecific co-assembly as confirmed by molecular dynamics simulations. Through this RSCA strategy, we achieved a controllable synthesis of a variety of functional mesoporous metal oxide composites (e.g., WO3, ZrO2, TiO2) with in-pore walls precisely decorated by various noble metal nanocrystals of tailored components (Au, Ag, Pt, Pd and their nanoalloys) and sizes (3.0-8.5 nm). As an example, the obtained mesoporous 0.5-Ag/WO3 material has a highly interconnected mesoporous structure and uniform 6.5 nm Ag nanocrystals confined in the mesopores, showing superior NO sensing performances with high sensitivity, good selectivity, and stability at low working temperature (127 °C). In situ spectroscopy study indicates that the NO sensing process involves a unique gas-solid reaction, where NO molecules are converted into chemisorbed NO x species over the sensitive materials, inducing a remarkable change of resistance and outputting a dramatic response signal.


  • Open Access

    Noggin Combined With Human Dental Pulp Stem Cells to Promote Skeletal Muscle Regeneration

    by Meng-Han Zhang, Li-Ming Yu, Wei-Hua Zhang, Jia-Jia Deng, Bing-Jing Sun, Mei-Hua Chen, Wei Huang, Jiao Li, Hua He, Xin-Xin Han, et al.

    A proper source of stem cells is key to muscle injury repair. Dental pulp stem cells (DPSCs) are an ideal source for the treatment of muscle injuries due to their high proliferative and differentiation capacities. However, the current myogenic induction efficiency of human DPSCs hinders their use in muscle regeneration due to the unknown induction mechanism. In this study, we treated human DPSCs with Noggin, a secreted antagonist of bone morphogenetic protein (BMP), and discovered that Noggin can effectively promote myotube formation. We also found that Noggin can accelerate the skeletal myogenic differentiation (MyoD) of DPSCs and promote the generation of Pax7+ satellite‐like cells. Noggin increased the expression of myogenic markers and the transcriptional and translational abundance of satellite cell (SC) markers in DPSCs. Moreover, BMP4 inhibited Pax7 expression and activated p‐Smad1/5/9, while Noggin eliminated BMP4‐induced p‐Smad1/5/9 in DPSCs. This finding suggests that Noggin antagonizes BMP by downregulating p‐Smad and facilitates the MyoD of DPSCs. Then, we implanted Noggin‐pretreated DPSCs combined with Matrigel into the mouse tibialis anterior muscle with volumetric muscle loss (VML) and observed a 73% reduction in the size of the defect and a 69% decrease in scar tissue. Noggin‐treated DPSCs can benefit the Pax7+ SC pool and promote muscle regeneration. This work reveals that Noggin can enhance the production of satellite‐like cells from the MyoD of DPSCs by regulating BMP/Smad signaling, and these satellite‐like cell bioconstructs might possess a relatively fast capacity for muscle regeneration.


  • Open Access

    Two-stage method of free gingival graft prior to periodontal regenerative surgery for the treatment of intrabony defects with insufficient keratinised tissue width: a study protocol for an open-label randomised controlled trial

    by Haohao Liu, Jialiang Liu, Mudi Guo, Xiaofeng Chen, Meihua Chen

    Introduction Guided tissue regeneration (GTR) combined with bone grafting for periodontal regenerative surgery has ideal clinical results for intrabony defect. However, some sites of intrabony defects often suffer from insufficient keratinised gingival width, which affects the efficacy and long-term prognosis of periodontal tissue regeneration. Free gingival graft (FGG) is an effective surgical procedure to widen the keratinised gingiva, but there are few clinical studies on FGG prior to GTR combination with bone grafting to improve clinical outcomes. Methods This study is an open-label randomised controlled trial. 68 patients with periodontitis with at least one intrabony defect depth with ≥3 mm are recruited and randomly grouped. In the test group, FGG is performed first, followed by GTR and bone grafting 3 months later; while in the control group, only periodontal tissue regenerative procedures are performed. After completion of all procedures, the patients will be recalled at 3 months, 6 months and 12 months and the relevant clinical and radiographic examinations will be carried out and statistical analysis of the data will also be performed. The present research has received approval from the Ethics Committee of Shanghai Stomatological Hospital (No.2022–007) on 4 August 2022. Discussion Exploring the effectiveness of the two-stage approach of FGG prior to periodontal tissue regenerative surgery for the treatment of keratinised gingival width deficient intrabony defects can provide a high-level evidence-based basis for the formulation of relevant treatment strategies in clinical practice. Ethics and dissemination The present research has received approval from the Ethics Committee of Shanghai Stomatological Hospital (No.2022–007) on 4 August 2022. The patients will be incorporated into this trial only after their written informed consent has been obtained. The study will be performed according to the 2013 revision of the Helsinki Declaration of 1975. Personal information of all subjects will be stored in the Department of Periodontology of Shanghai Stomatological Hospital. Data of the present research will be registered with the Clinical Trials Registry Platform. Additionally, we will disseminate the results through scientific journals. Trial registration Chinese Clinical Trial Registry, ID: ChiCTR 2200063180. Registered on 1 September 2022.

  • Open Access

    Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development

    by Yan Chen, Ning Jiang, Meihua Chen, Baiyan Sui, Xin Liu

    The mRNA vaccines have been considered effective for combating cancer. However, the core components of the mRNA vaccines against head and neck squamous cell carcinoma (HNSCC) and the effects remain unclear. Our study aims to identify effective antigens in HNSCC to develop mRNA vaccines for corresponding potential patients. Here, we analyzed alternative splicing and mutation of genes in TCGA-HNSCC samples and identified seven potential tumor antigens, including SREBF1, LUC7L3, LAMA5, PCGF3, HNRNPH1, KLC4, and OFD1, which were associated with nonsense-mediated mRNA decay factor expression, overall survival prognosis and the infiltration of antigen-presenting cells. Furthermore, to select suitable patients for vaccination, immune subtypes related to HNSCC were identified by consensus clustering analysis, and visualization of the HNSCC immune landscape was performed by graph-learning-based dimensionality reduction. To address the heterogeneity of the population that is suitable for vaccination, plot cell trajectory and WGCNA were also utilized. HNSCC patients were classified into three prognostically relevant immune subtypes (Cluster 1, Cluster 2, and Cluster 3) possessing different molecular and cellular characteristics, immune modulators, and mutation statuses. Cluster 1 had an immune-activated phenotype and was associated with better survival, while Cluster 2 and Cluster 3 were immunologically cold and linked to increased tumor mutation burden. Therefore, HNSCC patients with immune subtypes Cluster 2 and Cluster 3 are potentially suitable for mRNA vaccination. Moreover, the prognostic module hub genes screened seven genes, including IGKC, IGHV3-15, IGLV1-40, IGLV1-51, IGLC3, IGLC2, and CD79A, which could be potential biomarkers to predict prognosis and identify suitable patients for mRNA vaccines. Our findings provide a theoretical basis for further research and the development of anti-HNSCC mRNA vaccines and the selection of suitable patients for vaccination.